Literature DB >> 27793444

Radiation-induced fibrosis in the boost area after three-dimensional conformal radiotherapy with a simultaneous integrated boost technique for early-stage breast cancer: A multivariable prediction model.

C Hammer1, J H Maduro2, E J Bantema-Joppe2, A van der Schaaf2, H P van der Laan2, J A Langendijk2, A P G Crijns2.   

Abstract

BACKGROUND AND
PURPOSE: To develop a multivariable prediction model for the risk of grade⩾2 fibrosis in the boost area after breast conserving surgery (BCS) followed by three-dimensional conformal radiotherapy (RT) with a simultaneous integrated photon boost (3D-CRT-SIB), five years after RT.
MATERIAL AND METHODS: This prospective cohort study included 1,030 patients treated with RT for breast cancer (stage 0-III), after BCS. Data regarding physician-rated fibrosis and dose-volume parameters were available in 546 patients. A multivariable logistic regression model for grade⩾2 fibrosis was generated.
RESULTS: At 5years, grade⩾2 fibrosis was observed in 13.4% of the patients. The multivariable analysis resulted in a prediction model for grade⩾2 fibrosis in the boost area including three independent variables: patient age, breast volume receiving⩾55Gy (V55 CTV breast) and the maximum radiation dose in the breast (Dmax).
CONCLUSIONS: A multivariable prediction model was developed including age, V55 CTV breast and Dmax for grade⩾2 fibrosis in the boost area after breast cancer RT using a 3D-CRT-SIB technique. This model can be used to estimate the risk of fibrosis and to optimize dose distributions aiming at reducing this risk.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Fibrosis; Multivariable prediction model; NTCP; Radiotherapy

Mesh:

Year:  2016        PMID: 27793444     DOI: 10.1016/j.radonc.2016.10.006

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

1.  Radiation Fibrosis Syndrome Imitating Breast Cancer Recurrence; A Case Report.

Authors:  Dauren Sarsenov; Fatma Aktepe; Vahit Özmen
Journal:  J Breast Health       Date:  2017-01-01

2.  Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population.

Authors:  Jennifer J Hu; James J Urbanic; L Doug Case; Cristiane Takita; Jean L Wright; Doris R Brown; Carl D Langefeld; Mark O Lively; Sandra E Mitchell; Anu Thakrar; David Bryant; Kathy Baglan; Jon Strasser; Luis Baez-Diaz; Glenn J Lesser; Edward G Shaw
Journal:  J Clin Oncol       Date:  2018-07-10       Impact factor: 44.544

3.  Hypofractionation with concomitant boost using intensity-modulated radiation therapy in early-stage breast cancer in Mexico.

Authors:  María Yicel Bautista Hernandez; Pomponio José Lujan Castilla; Abril Antonia Quézada Bautista
Journal:  Rep Pract Oncol Radiother       Date:  2018-07-26

4.  Characterisation of fibrosis in chemically-induced rat mammary carcinomas using multi-modal endogenous contrast MRI on a 1.5T clinical platform.

Authors:  Neil P Jerome; Jessica K R Boult; Matthew R Orton; James A d'Arcy; Ashutosh Nerurkar; Martin O Leach; Dow-Mu Koh; David J Collins; Simon P Robinson
Journal:  Eur Radiol       Date:  2017-10-16       Impact factor: 5.315

5.  Dosimetric and radiobiological comparison of simultaneous integrated boost radiotherapy for early stage right side breast cancer between three techniques: IMRT, hybrid IMRT and hybrid VMAT.

Authors:  Suyan Bi; Rui Zhu; Zhitao Dai
Journal:  Radiat Oncol       Date:  2022-03-28       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.